Stanley Life IPO and itemizing: Time to get off the cos(tl)y sofa?

Stanley Life Ltd (SLL), the maker and retailer of luxurious furnishings, listed on the bourses in the present day at ₹499. The problem value on the higher band was ₹369. This interprets to an inventory achieve of 35.2 per cent. This itemizing achieve might be seen within the context of an total bullish sentiment prevailing … Read more

DXC expertise accused of delaying onboarding of over 4,800 campus recruits

IT-employee union Nascent Data Know-how Workers Senate (NITES) has accused DXC expertise, fashioned by the merger of Pc Sciences Company (CSC) and the Enterprise Companies enterprise of Hewlett Packard Enterprise (HPE), of a year-long delay in onboarding over 4,800 campus recruits. The union has written a letter to Mansukh Mandaviya, the Union minister of labour … Read more

Aditya Birla Group to speculate $50 million in manufacturing, R&D heart in Texas

Washington Aditya Birla Group has introduced an funding of $50 million in a producing and analysis and growth (R&D) heart in Texas. Aditya Birla Group’s Vice President of Gross sales and Advertising Scott Bastion stated the corporate might be making a $50-million funding exterior of Houston within the metropolis of Beaumont, Texas, the place it’ll … Read more

Sharp surge in frauds post-pandemic; Grant Thornton Bharat report

Because the Covid-19 pandemic modified the best way organisations perform, it additionally uncovered them to monetary fraud. Shift from onsite to distant work, lack of inside controls, and insufficient fraud consciousness have resulted in a surge in fraud, in line with a Grant Thornton Bharat report. “About 71 per cent of organisations have reported enterprise … Read more

Fintech platform LXME raises $1.2 million in a spherical led by Kalaari Capital

LXME, a monetary platform for ladies, has raised seed funding of $1.2 million, led by Kalaari Capital, via its CXXO initiative, which invests in ventures led by ladies entrepreneurs. Additionally learn:Fintech firms disburse file 10 crore loans in FY24, up 35% The spherical additionally noticed participation from notable traders like Yash Kela of Founders Collective … Read more

Lupin, Eugia recall merchandise from US market: USFDA

Drugmaker Lupin and a unit of Aurobindo Pharma are recalling merchandise from the American market as a consequence of manufacturing points, in keeping with the US well being regulator. As per the most recent Enforcement Report issued by the US Meals and Drug Administration (USFDA), a US-based unit of Lupin is recalling a drugs used … Read more

Status Estates plans to lift as much as ₹5,000 crore through QIP; monetise lodge biz

Realty agency Status Estates Initiatives Ltd plans to lift as much as ₹5,000 crore by promoting shares to institutional traders and in addition monetise its lodge enterprise. In keeping with a regulatory submitting on Friday, the corporate’s board permitted “elevating of funds by the use of issuance of fairness shares or different eligible securities for … Read more

Current actual cash recreation apps on Playstore to proceed; AIGF dubs it arbitrary, anti-competitive

Google on Friday, prolonged the grace interval, indefinitely, for current on-line, actual cash gaming on the Playstore, following which small gaming firms, and startups, accused the web big, of participating in arbitrary, and anti-competitive practices. Additionally learn:Actual-money gaming firms brace themselves for Google price, GST strain The grace interval, will proceed until the following replace, … Read more

Unikon.ai raises a seed funding of $2 million

Unikon.ai, a platform that permits customers to monetise their time and experience via networking, has raised $2 million from buyers together with Zerodha co-founder Nikhil Kamath, Lenskart’s Peyush Bansal, Shiprocket’s Vishesh Khurana, and Gaurav Khatri of Noise. The spherical additionally noticed participation from Dholakia Ventures, Nitin Jain & Vasant Sridhar (OfBusiness), Gaurav Khatri (Noise), and … Read more

Cipla, Solar Pharma ink non-exclusive settlement with Takeda on acid-reflux drug

Drugmakers Cipla and Solar Pharma have signed non-exclusive patent license agreements with Takeda Pharmaceutical Firm Restricted, respectively, for ‘Vonoprazan’ for India. The drug is used to deal with acid-related diseases amongst sufferers. Cipla and Solar Pharma will independently commercialise the drug in India below their respective trademark manufacturers. Earlier this month, Torrent Pharma had additionally … Read more